Are you a Stanford student interested in ETL and MS&E 472? If so, check out our FAQ!

Making a Difference in Biotech [Entire Talk]

George Scangos, Vir Biotechnology
With Jody Puglisi, Stanford School of Medicine

As the president and CEO of Vir Biotechnology, as well as in his role as head of BIO’s Coronavirus Collaboration Initiative, George Scangos has emerged as a global leader in the fight against COVID-19. In this conversation with Stanford structural biology professor Jody Puglisi, Dr. Scangos explains the challenge of building financially viable therapies for infectious diseases, talks about the current status of COVID-related research, and explores how to build an innovative and meaningful career in biotech.